Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab

Overview of attention for article published in Frontiers in Pharmacology, October 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,081 followers.

PubMed: https://t.co/A3JuysXavp Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab. Related Arti…

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab https://t.co/cuEZ2uguXp

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.